Any one-product company that receives good news about that product will likely attract investors. That was the case Wednesday with Amarin (NASDAQ: AMRN), which received very encouraging news about its single commercialized drug that day. As a result, its shares were trading more than 6% higher in late-session ...
motleyfoolusx:amrn
